Drug Manufacturers Gained Heavy Volume: ABBV, PFE, ARNA, LLY

Los Angelas, CA -- (SBWIRE) -- 01/22/2013 -- AbbVie Inc (NYSE:ABBV) was in the volume gaining stream, on January 18, 2013, the stock’s volume was 17.84 million shares, compared to average trading shares of 8.28 million. Tracking its past one month percentage change; the stock has shown an upward performance, having a positive change of +8.74% and the stock also gained a positive performance in its prior 3 months and grew +6.63%.

How Should Investors React To ABBV Now? Find Out Here

Pfizer Inc. (NYSE:PFE) announced on January 18 that the European Medicines Agency issued a positive outlook regarding the conditional marketing approval of its cancer drug bosutinib in the European Union for the cure of adult patients with certain types of leukemia. Following the announcement, shares of Pfizer ended down 1.08% at US$26.54. The company's 52-week range remained US$20.75 to US$26.96 with its market capitalization touching US$195.40 billion.

How Should Investors Trade PFE After The Recent Volatile Moves? Find Out Here

Arena Pharmaceuticals Inc (NASDAQ:ARNA) moved down 6.51% and closed at $9.77 on a traded volume of 20.32 million shares. Arena Pharmaceuticals has been restated by TheStreet Ratings as a sell with a ratings score of D- . Arena Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Will ARNA Extend Rally In The Coming Week? Find Out Here

Lilly & Co. (NYSE:LLY) was in the volume gaining stream, on January 18, 2013. The stock’s volume was 6.56 million shares, compared to average trading shares of 6.91 million. LLY surged +40.10% in its yearly performance and also escalated +1.22% in its quarterly performance. The day range of LLY remained $52.93- $53.77, while its 52 week price range was $38.30- $53.99. The market capitalization of the stock was 62.40 billion.
Should LLY a Buy Now? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com